These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2784238)
1. Effects of subacute administration of O,S,S-trimethyl phosphorodithioate on cellular and humoral immune response systems. Rodgers KE; Stern ML; Ware CF Toxicology; 1989 Feb; 54(2):183-95. PubMed ID: 2784238 [TBL] [Abstract][Full Text] [Related]
2. Effects of acute administration of O,S,S-trimethyl phosphorodithioate on the generation of cellular and humoral immune responses following in vitro stimulation. Rodgers KE; Leung N; Ware CF Toxicology; 1988 Oct; 51(2-3):241-53. PubMed ID: 3051516 [TBL] [Abstract][Full Text] [Related]
3. Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems. Rodgers KE; Imamura T; Devens BH Toxicol Appl Pharmacol; 1985 Nov; 81(2):310-8. PubMed ID: 3877352 [TBL] [Abstract][Full Text] [Related]
4. Effects of O,S,S-trimethyl phosphorodithioate on immune function. Rodgers KE; Leung N; Ware CF; Imamura T Toxicology; 1987 Feb; 43(2):201-16. PubMed ID: 3492784 [TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular and humoral immune responses by O,S,S-trimethyl phosphorodithioate, an impurity of commercial malathion. Thomas IK; Imamura T Toxicology; 1986 Apr; 39(1):1-12. PubMed ID: 3485840 [TBL] [Abstract][Full Text] [Related]
8. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affected. Rodgers KE; Imamura T; Devens BH Immunopharmacology; 1985 Dec; 10(3):171-80. PubMed ID: 2939039 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step. Rodgers KE; Grayson MH; Ware CF J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244 [TBL] [Abstract][Full Text] [Related]
10. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animals. Rodgers KE; Imamura T; Devens BH Toxicol Appl Pharmacol; 1987 Apr; 88(2):270-81. PubMed ID: 3494328 [TBL] [Abstract][Full Text] [Related]
11. Lung injury and delayed toxicity produced by O,S,S-trimethyl phosphorodithioate, an impurity of malathion. Konno N; Fukuto TR; Imamura T Toxicol Appl Pharmacol; 1984 Sep; 75(2):219-28. PubMed ID: 6474459 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effect of an impurity of malathion: inhibition of murine T- and B-lymphocyte responses by O,O,S-trimethyl phosphorothioate. Thomas IK; Imamura T Toxicol Appl Pharmacol; 1986 May; 83(3):456-64. PubMed ID: 2939594 [TBL] [Abstract][Full Text] [Related]
13. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigen. Rodgers KE; Imamura T; Devens BH Immunopharmacology; 1985 Dec; 10(3):181-9. PubMed ID: 3833856 [TBL] [Abstract][Full Text] [Related]
14. Topical exposure to 2-butoxyethanol alters immune responses in female BALB/c mice. Singh P; Zhao S; Blaylock BL Int J Toxicol; 2001; 20(6):383-90. PubMed ID: 11797820 [TBL] [Abstract][Full Text] [Related]